Locations:
Min Investment:
Max Investment:
Target Investment:
2023
2023
2023
BioFab Startup Lab
2018
2018
Anzu Partners is a venture capital and private equity firm that invests in breakthrough industrial technologies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. https://www.anzupartners.com/
2021
2021
CytoTronics is disrupting the traditional drug discovery process through a highly differentiated engineering approach. Spinning out from Harvard after a decade of research, our proprietary semiconductor-cell interface can deliver high-dimensional functional assessment of live-cell responses at scale. CytoTronics’ platform integrates the semiconductor-cell interface, live-cell biology, and machine learning, to generate more translational insights earlier in the drug discovery process, unlocking previously undruggable diseases.
2022
2022
BioFlyte® is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. Our instruments identify microbes including spores, vegetative bacteria, and viruses, bio-toxins, opioids, and other airborne threats to our safety and security.
2014 - 2018
2014 - 2018
2010 - 2014
2010 - 2014
2010 - 2013
Market Development in MENA (Hannover, Germany) Parts Complexity Reduction in Manufacturing (Lousado, Portugal) eXplore R&D Program (Hannover, Germany)
2009 - 2010
2009 - 2010